What Story Does Your Model Tell?
How AI’s societal impact is being affected and directed
What's New
Actuarial Insights from Dubai
A conversation with Owais Ansari, FSA, on thinking globally and acting locally
Explainable AI, Generative Models, and the Next Era of Actuarial Science
A conversation with Kittipon Sarnvanichpitak, FSA, on incorporating AI in decision-making and more
Voices of Tomorrow, Part 3 — Adapting to Change
A conversation with Marcel Chang, FSA, CERA, on tackling climate risk and emerging trends on a global stage
Actuarial Insights from Toronto
A conversation with Lan Tong, FSA, FCIA, on perseverance, adaptability and sacrifice
Trending
Changes, Opportunities and Challenges in the Japanese Insurance Market
Q&A with Katherine Wong, FIAA, head of Pricing and Guideline Asia Pacific at SCOR
Vietnamese Insurance Market Insights
A conversation with Phuong Chung Ba, FSA, chairman of TC Advisors at Techcombank
Pharmaceutical Patent Regulation in the United States
There are many costs (and steps) to bring a drug to market